Foresee Pharmaceuticals Co., Ltd.

Quick facts

Phase 2 pipeline

• FP-025 capsules
• linvemastat · Other
• Mirivadelgat · Other

Phase 1 pipeline

• Cohort 1 - FP-045 oral solution
• FP-020
• FP-025

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Foresee Pharmaceuticals Co., Ltd. portfolio CI brief
• Foresee Pharmaceuticals Co., Ltd. pipeline updates RSS